Results 171 to 180 of about 49,053 (243)

Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024. [PDF]

China CDC Wkly
Ma C, Yang J, Liu A, Qian Z, Liu Z, Ge Y, Xu Y, Zhu Z, Wei H, Peng Z, Yin G, Hu Z.   +11 more
europepmc   +1 more source

Genome Sequence and Host Range Investigation of Cluster CV Phage Spink. [PDF]

MicroPubl Biol
Smith E, Cordero-Morales AE, Padilla-Crespo E, Tan EH, Reyna N, Plymale R.   +5 more
europepmc   +1 more source

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025. [PDF]

Euro Surveill
van Kampen J, Voermans J, Soochit W, Mesplède T, van de Laar T, van der Reijden W, Burger D, Shalev N, van Sighem A, Bezemer D, Jurriaans S, van der Vaart T, de Jong H, van der Valk M.   +13 more
europepmc   +1 more source

Cascading recombinase memory switch for programmable and stable gene expression in Pseudomonas putida. [PDF]

Nucleic Acids Res
Hernández-Sancho JM, Volke DC, Nikel PI.   +2 more
europepmc   +1 more source

Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]

Front Immunol
Wang H, Yuan J, Wang H.
europepmc   +1 more source

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK

, 2013
Collingwood, S P, Pryde, D C, Anderson, RJ, Collingwood, SP, Pryde, DC, Anderson, Rosaleen, Alderton, W K, Alderton, WK   +7 more
core  

Effect of naturally occurring polymorphisms on HIV-1 integrase structure and dolutegravir binding in subtypes A1 and D

Ssekagiri A, Ssemwanga D, Bbosa N, Kateete DP, Jjingo D.   +4 more
europepmc   +1 more source

Modular toolkit to facilitate molecular manipulations in mycobacteria. [PDF]

J Bacteriol
Khuntia AK, Dabla A, Kapoor Y, Chakraborty A, Arputharaj PE, Nandicoori VK.   +5 more
europepmc   +1 more source

Clinical presentation and effectiveness of antiretroviral therapy in newly diagnosed people living with HIV before, during and after the COVID-19 pandemic. [PDF]

BMJ Public Health
Carbone A, Lombardi F, Tiecco G, Iannone V, Logiudice J, Salvo PF, Scoppettuolo G, Gerami R, Cesanelli F, Salvi M, Cingolani A, Castelli F, Di Giambenedetto S, Torti C, Quiros-Roldan E.   +14 more
europepmc   +1 more source

A new-engineered integrative tool to target the terminal compartment of the Streptomyces chromosome. [PDF]

Appl Microbiol Biotechnol
Delhaye N, Pélé FR, Jaffal H, Lautru S, Leh H, Bury-Moné SG.   +5 more
europepmc   +1 more source